The Effect of A1 Adenosine Receptor in Diabetic Megalin Loss with Caspase-1/IL18 Signaling [Corrigendum]

Abstract

Tian D, Shi X, Zhao Y, et al. Diabet Metab Syndr Obes. 2019;12:1583– 1596.The authors of this paper have advised that Figures 5 and 6 are incorrect. The authors provided only one actin control for each treatment. However, their different target proteins had their own matched actin from the same experiment. This does not change the conclusion of the paper. The authors apologize for this error.Read the original article

Keywords

• a1 adenosine receptor
• diabetic nephropathy
• caspase-1
• megalin